← All organizations

Trevi Therapeutics

For profitWebsite ↗

Also known as: Trevi Therapeutics | Trevi Therapeutics, Inc | Trevi Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 30, 2025

Timeline

2010s

Jun 1, 2011
Trevi Therapeutics— Founded

Drugs by trial phase (4 distinct, 13 trials)

Phase 3 (1 own, 0 via acquisition)

nalbuphine

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (24)

NCT07015398Lead sponsorPhase 1Jun 30, 2025
NCT07036029OfficialPhase 1Jun 30, 2025
NCT07036029Lead sponsorPhase 1Jun 30, 2025
NCT07015398OfficialPhase 1Jun 30, 2025
NCT05962151Lead sponsorPhase 2Nov 30, 2023
NCT05962151Study directorPhase 2Nov 30, 2023
NCT05964335Lead sponsorPhase 2Oct 1, 2023
NCT05964335Study directorPhase 2Oct 1, 2023
NCT04030026Study directorPhase 2Aug 8, 2019
NCT04030026Lead sponsorPhase 2Aug 8, 2019
NCT04020016Lead sponsorPhase 1Oct 24, 2018
NCT04020016Study directorPhase 1Oct 24, 2018
NCT03497975Lead sponsorPhase 2/Phase 3Aug 7, 2018
NCT04018664Lead sponsorPhase 1May 29, 2018
NCT04018664Study directorPhase 1May 29, 2018

Details

Founded: Sandy Hook, CT, US Jun 1, 2011
Last known activity: Jun 30, 2025